{"a":[{"_":"J&J innovative medicine chief Jennifer Taubert to retire, handing reins to North America head","$":{"href":"/pharma/jj-innovative-medicine-chief-jennifer-taubert-retire-handing-reins-north-america-head","hreflang":"en"}}]}

Neutral

AI Analysis

Summary

Johnson & Johnson announced that Tom Cavanaugh will become the leader of its innovative medicines business, taking over from Jennifer Taubert starting September 1, 2026.

Importance:3/10

Sentiment:

0.00

management changeleadership transitioninnovative medicines

Related Companies

$JNJ

Read the original article

Published by FiercePharma on August 4, 2026 10:36 AM

Read Original